IBM (NYSE: IBM) fellow John Cohn knows a thing or two about innovation. He has 116 patents and 36 technical papers to his name, and has helped direct IBM through four decades of computing innovation.

Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Suzanne is a content marketer, writer, and fact-checker. She holds a ...

While primarily a theoretical tool, the S-curve can have a practical impact when forecasting market changes and planning ...

As the leader of one of the world’s first smartphone development projects, and having consulted for six years with Harvard Prof. Clayton Christensen as he translated his theory of disruptive ...

This episode of the Marketing Smarts Live Show features David Aaker, a renowned figure in the world of marketing. Together with host George B. Thomas, he delves into the fascinating concept of ...

His answer surprised me: “I don’t know how, I just know how to describe it.” Christensen described it well. He shared compelling examples. He argued that companies, and entire industries, can be ...

Though the business world glorifies big disruptive ideas, in reality, most progress is achieved by implementing hundreds or thousands of minor improvements that can have a big cumulative impact.

There are traditional growth stocks, and then there are disruptive, innovative growth stocks — the latter of which are being made famous by exchange traded funds such as the ARK Innovation ETF ...

Best practices, scalable, transformational — there’s been a consistent flow of business buzzwords making their way into healthcare, and one of the latest is “disruptive innovation.” But an article in ...

Clayton M. Christensen, a prominent Utah-born business theorist and consultant, devout Latter-day Saint and framer of the influential concept of “disruptive innovation,” died Thursday. He was 67.

Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey What a difference a ...